跳到內容

腫瘤科(兒科)

有效止血方法

抗纖維蛋白溶解劑

Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies. (開啟新視窗)

Antun AG, Gleason S, Arellano M, Langston AA, McLemore ML, Gaddh M, el Rassi F, Bernal-Mizrachi L, Galipeau J, Heffner LT Jr, Winton EF, Khoury HJ.

出處‎: Cancer 2013;119(21):3784-7.

檢索‎: PubMed 23921838

DOI碼‎: 10.1002/cncr.28253

https://www.ncbi.nlm.nih.gov/pubmed/23921838 (開啟新視窗)

Low dose bolus aminocaproic acid: an alternative to platelet transfusion in thrombocytopenia? (開啟新視窗)

Chakrabarti S, Varma S, Singh S, Kumari S

出處‎: Eur J Haematol 1998;60(5):313-4.

檢索‎: PubMed 9654162

DOI碼‎: 10.1111/j.1600-0609.1998.tb01046.x

https://www.ncbi.nlm.nih.gov/pubmed/9654162 (開啟新視窗)

The use of antifibrinolytics in pediatric patients with hypoproliferative thrombocytopenia. (開啟新視窗)

Delaney M, Matthews DC, Gernsheimer TB

出處‎: Pediatr Blood Cancer 2017;64(12):e26641.

檢索‎: PubMed 28544698

DOI碼‎: 10.1002/pbc.26641

https://www.ncbi.nlm.nih.gov/pubmed/28544698 (開啟新視窗)

A controlled trial of tranexamic acid therapy for the reduction of bleeding during treatment of acute myeloid leukemia. (開啟新視窗)

Shpilberg O, Blumenthal R, Sofer O, Katz Y, Chetrit A, Ramot B, Eldor A, Ben-Bassat I.

出處‎: Leuk Lymphoma 1995;19(1-2):141-4.

檢索‎: PubMed 8574160

DOI碼‎: 10.3109/10428199509059668

https://www.ncbi.nlm.nih.gov/pubmed/8574160 (開啟新視窗)

重組活化第七凝血因子(rFVIIa)

Pediatric off-label use of recombinant factor VIIa. (開啟新視窗)

Alten JA, Benner K, Green K, Toole B, Tofil NM, Winkler MK.

出處‎: Pediatrics 2009;123(3):1066-72.

檢索‎: PubMed 19255041

DOI碼‎: 10.1542/peds.2008-1685

https://www.ncbi.nlm.nih.gov/pubmed/19255041 (開啟新視窗)

Recombinant activated factor VII usage in life threatening hemorrhage: a pediatric experience. (開啟新視窗)

Bhat S, Yadav SP, Anjan M, Dinand V, Sachdeva A.

出處‎: Indian J Pediatr 2011;78(8):961-8.

檢索‎: PubMed 21328080

DOI碼‎: 10.1007/s12098-011-0364-6

https://www.ncbi.nlm.nih.gov/pubmed/21328080 (開啟新視窗)

Safety and efficacy of recombinant factor VIIa by pediatric age cohort: reassessment of compassionate use and trial data supporting US label. (開啟新視窗)

Croteau SE, Nakar C, Neufeld EJ, Shapiro A, Cooper DL

出處‎: Pediatr Blood Cancer 2016;63(10):1822-8.

檢索‎: PubMed 27232114

DOI碼‎: 10.1002/pbc.26082

https://www.ncbi.nlm.nih.gov/pubmed/27232114 (開啟新視窗)

Use of recombinant factor VIIa prior to lumbar puncture in pediatric patients with acute leukemia. (開啟新視窗)

Das P, Carcao M, Hitzler J

出處‎: Pediatr Blood Cancer 2006;47(2):206-9.

檢索‎: PubMed 16007583

DOI碼‎: 10.1002/pbc.20467

https://www.ncbi.nlm.nih.gov/pubmed/16007583 (開啟新視窗)

A comprehensive review of rFVIIa use in a tertiary care pediatric center. (開啟新視窗)

Heller M, Lau W, Pazmino-Canizares J, Brandão LR, Carcao M

出處‎: Pediatr Blood Cancer 2008;50(5):1013-7.

檢索‎: PubMed 17960639

DOI碼‎: 10.1002/pbc.21375

https://www.ncbi.nlm.nih.gov/pubmed/17960639 (開啟新視窗)

Recombinant activated factor VII for severe gastrointestinal bleeding after chemotherapy in an infant with acute megakaryoblastic leukemia. (開啟新視窗)

Kurekci AE, Atay AA, Okutan V, Yavuz ST, Ozcan O

出處‎: Blood Coagul Fibrinolysis 2005;16(2):145-7.

檢索‎: PubMed 15741803

DOI碼‎: 10.1097/01.mbc.0000161569.66764.70

https://www.ncbi.nlm.nih.gov/pubmed/15741803 (開啟新視窗)

Off-label use of recombinant factor VIIa in pediatric patients. (開啟新視窗)

McQuilten ZK, Barnes C, Zatta A, Phillips LE; Haemostasis Registry Steering Committee

出處‎: Pediatrics 2012;129(6):e1533-40.

檢索‎: PubMed 22641758

DOI碼‎: 10.1542/peds.2011-2561

https://www.ncbi.nlm.nih.gov/pubmed/22641758 (開啟新視窗)

Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. (開啟新視窗)

Yilmaz D, Karapinar B, Balkan C, Akisü M, Kavakli K.

出處‎: Pediatr Hematol Oncol 2008;25(4):301-11.

檢索‎: PubMed 18484474

DOI碼‎: 10.1080/08880010802016904

https://www.ncbi.nlm.nih.gov/pubmed/18484474 (開啟新視窗)

迷你寧(去氨加壓素)(DDAVP)

The use of DDAVP in children with bleeding disorders. (開啟新視窗)

Ben-Ami T, Revel-Vilk S

出處‎: Pediatr Blood Cancer 2013;60 Suppl 1:S41-3.

檢索‎: PubMed 23109357

DOI碼‎: 10.1002/pbc.24335

https://www.ncbi.nlm.nih.gov/pubmed/23109357 (開啟新視窗)

局部止血劑

The use of Tachosil as hemostatic sealant in nephron sparing surgery for Wilms tumor: preliminary observations. (開啟新視窗)

Mele E, Ceccanti S, Schiavetti A, Bosco S, Masselli G, Cozzi DA

出處‎: J Pediatr Surg 2013;48(3):689-94.

檢索‎: PubMed 23480936

DOI碼‎: 10.1016/j.jpedsurg.2013.01.019

https://www.ncbi.nlm.nih.gov/pubmed/23480936 (開啟新視窗)